Physician

Daniel James Barkdoll, M.D.

According to 2025 Medicare claims, Daniel Barkdoll, M.D. (NPI: 1154349744) practices family practice in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47025-2048. Barkdoll is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Barkdoll's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 420 traditional Medicare patients, billed 3,059 HCPCS/CPT codes, and received $96,105 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 11,219 prescription claims across 744 beneficiaries totaling $902,950 in drug costs, led by Eliquis (Apixaban). DME data shows 25 claims. Open Payments data shows 111 records totaling $2,068. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $98,330 and ending at $96,105. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $13,157 and ending at $7,237.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	457	2,737	$98,330
2016	520	2,989	$108,639
2017	724	3,424	$129,718
2018	527	3,157	$117,642
2019	461	2,805	$100,289
2020	265	1,731	$53,759
2021	418	1,992	$98,665
2022	386	1,928	$99,416
2023	336	1,918	$97,393
2024	420	3,059	$96,105

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	457	10,730	$707,460
2016	485	11,799	$766,692
2017	650	21,234	$1,332,139
2018	684	23,304	$1,535,389
2019	692	18,882	$1,433,655
2020	522	9,051	$828,086
2021	646	9,141	$834,110
2022	672	9,476	$868,053
2023	714	11,082	$900,398
2024	744	11,219	$902,950

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	264	$17,360
2016	70	436	$18,034
2017	86	457	$22,427
2018	74	370	$13,236
2019	39	286	$7,234
2020	24	274	$6,688
2021	21	183	$3,350
2022	14	80	$5,373
2023	N/R	82	$6,912
2024	N/R	25	$209

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	156	156	$124
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	105	154	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	278	$52
G0008	Administration of influenza virus vaccine	99	102	$30
36415	Insertion of needle into vein for collection of blood sample	117	145	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	145	5,532	$108,046
Jardiance	Empagliflozin	63	4,094	$81,173
Farxiga	Dapagliflozin Propanediol	55	3,650	$67,814
Ozempic	Semaglutide	34	1,780	$58,005
Nuplazid	Pimavanserin Tartrate	12	360	$57,715

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	25	$209

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$2,068	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel James Barkdoll, M.D.?

Tedicare shows public-source Medicare data for Daniel James Barkdoll, M.D. (NPI 1154349744), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel James Barkdoll, M.D. have ACO affiliation data?

Daniel James Barkdoll, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Daniel James Barkdoll, M.D.?

Daniel James Barkdoll, M.D. is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Daniel James Barkdoll, M.D. have Open Payments data?

Daniel James Barkdoll, M.D. has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.